Revision history of "Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality" (Q43831888)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 March 2024

29 October 2023

  • curprev 11:3211:32, 29 October 2023 KrBot talk contribs 39,306 bytes −1 Set a claim value: title (P1476): Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality undo (restore)
  • curprev 11:3211:32, 29 October 2023 KrBot talk contribs 39,307 bytes −1 Changed Dutch label: Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality undo (restore)
  • curprev 11:3211:32, 29 October 2023 KrBot talk contribs 39,308 bytes −1 Changed English label: Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality undo (restore)

24 October 2020

19 November 2019

30 April 2019

1 January 2019

24 December 2018

27 November 2017